See All Slides - tctmd.com

Slides

Presentation TCT 2012

MitraClip for Functional MR: RESHAPE: Update and Expectations

Presenter: A. Pieter Kappetein

October 24, 2012

Presentation TCT 2012

Recanalization of Bilateral Carotid Artery Occlusion

Presenter: Paul Hsien-Li Kao

October 24, 2012

Presentation TCT 2012

Lessons from the HORIZONS-AMI and INFUSE-AMI Trials

Presenter: Helen Parise

October 24, 2012

Presentation TCT 2012

Perspectives on Direct Annuloplasty: Who Are the Right and Wrong Patients (with Case Examples)

Presenter: Eberhard Grube

October 24, 2012

Presentation TCT 2012

Good Intentions Gone Bad: Problems with AUC

Presenter: Steven Marso

October 24, 2012

Presentation TCT 2012

Micardia Update: Surgical and Percutaneous Device Progress

Presenter: Maurice Buchbinder

October 24, 2012

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

Presentation TCT 2012

ADAPT-DES IVUS Substudy: Utility of IVUS in Delineating the Mechanism of and Preventing Stent Thrombosis

Presenter: Akiko Maehara

October 24, 2012

Presentation TCT 2012

SFA Intervention: State of the Art Today and in 2020

Presenter: Gary Ansel

October 24, 2012

Presentation TCT 2012

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Presenter: C. Michael Gibson

October 24, 2012

Advertisement

Slides

MitraClip for Functional MR: RESHAPE: Update and Expectations

Recanalization of Bilateral Carotid Artery Occlusion

Lessons from the HORIZONS-AMI and INFUSE-AMI Trials

Perspectives on Direct Annuloplasty: Who Are the Right and Wrong Patients (with Case Examples)

Good Intentions Gone Bad: Problems with AUC

Micardia Update: Surgical and Percutaneous Device Progress

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

ADAPT-DES IVUS Substudy: Utility of IVUS in Delineating the Mechanism of and Preventing Stent Thrombosis

SFA Intervention: State of the Art Today and in 2020

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content